Hepatocellular Carcinoma: Signal Intensity at Gadoxetic Acid-enhanced MR Imaging-Correlation with Molecular Transporters and Histopathologic Features

被引:283
作者
Kitao, Azusa [1 ,2 ]
Zen, Yoh [2 ]
Matsui, Osamu [1 ]
Gabata, Toshifumi [1 ]
Kobayashi, Satoshi [1 ]
Koda, Wataru [1 ]
Kozaka, Kazuto [1 ]
Yoneda, Norihide [1 ]
Yamashita, Tatsuya [3 ]
Kaneko, Shuichi [3 ]
Nakanuma, Yasuni [2 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa 9208640, Japan
[2] Kanazawa Univ, Grad Sch Med Sci, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan
[3] Kanazawa Univ, Grad Sch Med Sci, Dept Gastroenterol, Kanazawa, Ishikawa 9208640, Japan
关键词
GD-EOB-DTPA; FOCAL LIVER-LESIONS; CONTRAST AGENT; POLYPEPTIDE; GENE; IDENTIFICATION; ORGANIZATION; SAFETY;
D O I
10.1148/radiol.10092214
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To analyze the correlation between signal intensity in the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance (MR) imaging and the expression of hepatocyte transporters with histopathologic features in hepatocellular carcinoma (HCC). Materials and Methods: Institutional ethics committee approval and informed consent were obtained. Forty surgically resected HCCs were classified as hypointense (n = 32) or iso- or hyperintense (n = 8) on the basis of findings in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging. The following were compared between hypointense and iso- or hyperintense HCCs: the time-signal intensity curves at gadoxetic acid-enhanced MR imaging, the expression levels of seven transporters (four organic anion-transporting polypeptides [OATPs] and three multidrug-resistant proteins [MRPs]) at polymerase chain reaction (PCR) (for 22 nodules), results of immunostaining of OATP8, and histologic features. Statistical analysis (unpaired t test, Mann-Whitney test, chi(2) test, and Fisher exact test) was performed for each result. Results: On the time-signal intensity curves, hypointense HCCs showed a decreasing pattern, whereas iso- or hyperintense HCCs showed an increasing pattern after the dynamic phase. PCR revealed that expression of OATP8 (an uptake transporter) in hypointense HCCs was lower and that in iso- or hyperintense HCCs was higher than in background liver (P < .001). The expression level of MRP3 (a sinusoidal export transporter) showed a similar trend to that of OATP8 (P < .001). Immunostaining revealed that OATP8 expression was weak in hypointense HCCs, whereas it was sustained in iso- or hyperintense HCCs (P < .001). At histologic examination, a pseudoglandular proliferation pattern with bile plugs was more commonly observed in iso- or hyperintense HCCs than in hypointense HCCs (P = .01 for proliferation patterns and P = .006 for bile plugs). Conclusion: The enhancement ratio of HCCs in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging positively correlated with expression levels of OATP8 and MRP3, indicating that gadoxetic acid is taken up by OATP8 and excreted by MRP3. (C) RSNA, 2010
引用
收藏
页码:817 / 826
页数:10
相关论文
共 35 条
[1]   Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1 [J].
Abe, T ;
Kakyo, M ;
Tokui, T ;
Nakagomi, R ;
Nishio, T ;
Nakai, D ;
Nomura, H ;
Unno, M ;
Suzuki, M ;
Naitoh, T ;
Matsuno, S ;
Yawo, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) :17159-17163
[2]   Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media [J].
Bartolozzi, Carlo ;
Crocetti, Laura ;
Lencioni, Riccardo ;
Cioni, Dania ;
Della Pina, Clotilde ;
Campani, Daniela .
EUROPEAN RADIOLOGY, 2007, 17 (10) :2519-2530
[3]   Efficacy and safety of MR imaging with liver-specific contrast agent: US Multicenter Phase III study [J].
Bluemke, DA ;
Sahani, D ;
Amendola, M ;
Balzer, T ;
Breuer, J ;
Brown, JJ ;
Casalino, DD ;
Davis, PL ;
Francis, IR ;
Krinsky, G ;
Lee, FT ;
Lu, D ;
Paulson, EK ;
Schwartz, LH ;
Siegelman, ES .
RADIOLOGY, 2005, 237 (01) :89-98
[4]   PHASE-I CLINICAL-EVALUATION OF GD-EOB-DTPA AS A HEPATOBILIARY MR CONTRAST AGENT - SAFETY, PHARMACOKINETICS, AND MR-IMAGING [J].
HAMM, B ;
STAKS, T ;
MUHLER, A ;
BOLLOW, M ;
TAUPITZ, M ;
FRENZEL, T ;
WOLF, KJ ;
WEINMANN, HJ ;
LANGE, L .
RADIOLOGY, 1995, 195 (03) :785-792
[5]   Hepatocellular carcinoma in the cirrhotic liver: Gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis [J].
Hecht, EM ;
Holland, AE ;
Israel, GM ;
Hahn, WY ;
Kim, DC ;
West, AB ;
Babb, JS ;
Taouli, B ;
Lee, VS ;
Krinsky, GA .
RADIOLOGY, 2006, 239 (02) :438-447
[6]  
Hirohashi I.K., 2000, Pathology and genetics of tumours of the digestive system, P157
[7]   A novel human hepatic organic anion transporting polypeptide (OATP2) - Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters [J].
Hsiang, BN ;
Zhu, YJ ;
Wang, ZQ ;
Wu, YL ;
Sasseville, V ;
Yang, WP ;
Kirchgessner, TG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (52) :37161-37168
[8]   Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: Correlation with histopathologic findings and spiral CT - Initial observations [J].
Huppertz, A ;
Haraida, S ;
Kraus, A ;
Zech, CJ ;
Scheidler, J ;
Breuer, J ;
Helmberger, TK ;
Reiser, MF .
RADIOLOGY, 2005, 234 (02) :468-478
[9]   Improved detection of focal liver lesions at MR imaging: Multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings [J].
Huppertz, A ;
Balzer, T ;
Blakeborough, A ;
Breuer, L ;
Giovagnoni, A ;
Heinz-Peer, G ;
Laniado, M ;
Manfredi, RM ;
Mathieu, DG ;
Mueller, D ;
Reimer, P ;
Robinson, PJ ;
Strotzer, M ;
Taupitz, M ;
Vogl, TJ .
RADIOLOGY, 2004, 230 (01) :266-275
[10]   Experimental hepatic dysfunction: Evaluation by MRI with Gd-EOB-DTPA [J].
Kim, T ;
Murakami, T ;
Hasuike, Y ;
Gotoh, M ;
Kato, N ;
Takahashi, M ;
Miyazawa, T ;
Narumi, Y ;
Monden, M ;
Nakamura, H .
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1997, 7 (04) :683-688